Furthermore, the new subclassification of diabetes, identifying insulin resistance as a central risk factor for the development of DKD, allows to better predict the disease progression and outcome, and to design personalized treatments for patients in each subclass, including the severely insulin resistant ones at high risk for DKD.104. Here, INS is linked to Insulin resistance.